CombiMatrix Starts Trading on Nasdaq Global Market

Nov 19, 2007

NEW YORK (GenomeWeb News) – CombiMatrix’s stock began trading on the Nasdaq Global Market today.

The stock had been trading on the Nasdaq Capital Market since CombiMatrix split off from its former parent company Acacia Research in August.

CombiMatrix, which now trades under the symbol CBMX, was trading at $6.77 a share late Monday afternoon.

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.